[CBM] Cambrex Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 1.85 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 54.15 Change: 1.45 (2.75%)
Ext. hours: Change: 0 (0%)

chart CBM

Refresh chart

Strongest Trends Summary For CBM

CBM is in the medium-term up 21% above S&P in 2 months and down -28% below S&P in 1 year. In the long-term up 872% in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. The company serves generic drug companies, and companies that discover and commercialize new small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Fundamental Ratios
Shares Outstanding31.98 M EPS2.85 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -20.81% Sales Growth - Q/Q-40.05% P/E20.14
P/E To EPS Growth P/S4.8 P/BV7.6 Price/Cash Per Share
Price/Free Cash Flow44.54 ROA13.37% ROE26.34% ROI17.57%
Current Ratio2.2 Quick Ratio1.18 Long Term Debt/Equity0.47 Debt Ratio0.43
Gross Margin35.31% Operating Margin16.19% Net Profit Margin16.66% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.6 M Cash From Investing Activities-12.04 M Cash From Operating Activities35.37 M Gross Profit29.08 M
Net Profit7.99 M Operating Profit12.67 M Total Assets481.08 M Total Current Assets233.17 M
Total Current Liabilities106.17 M Total Debt60 M Total Liabilities236.88 M Total Revenue77.53 M
Technical Data
High 52 week68.4 Low 52 week35.8 Last close42.83 Last change2.07%
RSI71.71 Average true range1.25 Beta1.21 Volume174.76 K
Simple moving average 20 days9.52% Simple moving average 50 days8.85% Simple moving average 200 days-13.9%
Performance Data
Performance Week8.43% Performance Month12.12% Performance Quart-3.54% Performance Half-34.61%
Performance Year-20.17% Performance Year-to-date13.43% Volatility daily1.89% Volatility weekly4.22%
Volatility monthly8.65% Volatility yearly29.97% Relative Volume145.8% Average Volume382.55 K
New High New Low

News

2019-06-12 10:24:29 | Calculating The Fair Value Of Cambrex Corporation NYSE:CBM

2019-06-11 08:03:48 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-06-08 08:02:17 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-06-06 09:30:01 | CBM vs. ALKS: Which Stock Should Value Investors Buy Now?

2019-06-06 08:03:00 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-06-04 08:03:01 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-06-04 08:00:00 | Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site

2019-05-29 10:00:00 | Cambrex to Present at Upcoming Investor Conferences in June

2019-05-23 09:19:01 | The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology

2019-05-22 07:21:11 | 5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon

2019-05-21 09:30:01 | CBM vs. TECH: Which Stock Is the Better Value Option?

2019-05-21 09:04:19 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-05-10 10:20:02 | Can Cambrex CBM Run Higher on Rising Earnings Estimates?

2019-05-07 08:03:58 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-05-03 03:40:12 | Edited Transcript of CBM earnings conference call or presentation 2-May-19 12:30pm GMT

2019-05-02 08:05:12 | Cambrex CBM Surpasses Q1 Earnings Estimates

2019-05-02 06:57:32 | Cambrex: 1Q Earnings Snapshot

2019-05-02 06:40:00 | Cambrex Reports First Quarter 2019 Financial Results

2019-04-30 10:45:00 | Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019

2019-04-25 10:34:02 | Cambrex CBM to Report Q1 Results: Wall Street Expects Earnings Growth

2019-04-23 08:00:00 | Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan

2019-04-17 11:29:22 | Update: Cambrex NYSE:CBM Stock Gained 80% In The Last Five Years

2019-04-10 08:00:00 | Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA

2019-04-09 10:47:25 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-03-29 07:25:00 | Factors of Influence in 2019, Key Indicators and Opportunity within Nutanix, Steel Dynamics, Audentes Therapeutics, Comfort Systems, LHC Group, and Cambrex — New Research Emphasizes Economic Growth

2019-03-26 08:22:18 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-03-26 08:00:00 | Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility

2019-03-19 09:47:14 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-03-14 08:00:00 | Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan

2019-03-13 15:38:56 | Do You Like Cambrex Corporation NYSE:CBM At This P/E Ratio?

2019-03-12 09:30:01 | Should Value Investors Pick Cambrex Corporation CBM Stock?

2019-02-18 08:03:31 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-02-17 08:20:00 | 3 Top Biotech Stocks to Buy in February

2019-02-15 09:19:51 | CBM Missed Earnings by Over 90%

2019-02-13 15:58:24 | Cambrex Corp CBM Q4 2018 Earnings Conference Call Transcript

2019-02-13 11:25:00 | Why Cambrex Corporation Is Tanking Today

2019-02-13 08:05:01 | Cambrex CBM Surpasses Q4 Earnings Estimates

2019-02-13 07:10:40 | Cambrex: 4Q Earnings Snapshot

2019-02-13 06:40:00 | Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-11 09:24:02 | Cambrex CBM Upgraded to Buy: Here's What You Should Know

2019-02-08 15:47:09 | Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019

2019-02-01 08:01:47 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-31 09:30:02 | CBM or ILMN: Which Is the Better Value Stock Right Now?

2019-01-30 08:01:44 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-24 08:02:41 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-18 09:10:02 | Is Cambrex CBM a Great Value Stock Right Now?

2019-01-16 08:01:49 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-15 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-09 09:30:02 | CBM or ALKS: Which Is the Better Value Stock Right Now?

2019-01-08 11:35:40 | Have Insiders Been Selling Cambrex Corporation NYSE:CBM Shares?